Medicine and Dentistry
Infection
90%
Transplantation
52%
Mycosis
44%
Disease
37%
Cohort Effect
34%
Human Immunodeficiency Virus
29%
Infective Endocarditis
29%
COVID-19
28%
Systemic Mycosis
25%
Immunocompromised Patient
25%
Disseminated Herpes Zoster
21%
Cryptococcosis
20%
Endocarditis
18%
Apoplexy
18%
Biological Therapy
17%
Rheumatoid Arthritis
16%
Histoplasmosis
15%
Invasive Aspergillosis
15%
Sepsis
14%
Cryptococcal Meningitis
12%
Antifungal Therapy
12%
Prospective Cohort Study
11%
Opportunistic Infection
11%
Fluconazole
11%
Solid Organ Transplantation
11%
Amphotericin B
10%
Diagnosis
10%
Clinician
10%
Clinical Feature
10%
Antifungal Agent
9%
Central Nervous System
9%
Surgery
9%
Inflammatory Disorder
9%
Intensive Care Unit
9%
Pathogen
9%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Immunosuppressive Treatment
8%
Race Difference
8%
Kidney Graft
8%
Bloodstream Infection
8%
Autoimmune Disease
7%
Mucormycosis
7%
Clinical Management
7%
Coccidioidomycosis
7%
Silo-Filler's Disease
7%
Biological Product
7%
Tumor Necrosis Factor
7%
Itraconazole
7%
Observational Study
7%
Varicella Zoster Vaccine
6%
Keyphrases
Solid Organ Transplant Recipients
38%
Epidemiology
37%
Histoplasmosis
35%
Confidence Interval
31%
Fungal Infection
28%
Rheumatoid Arthritis
28%
COVID-19
25%
Fluconazole
22%
Invasive Fungal Infection
22%
Infective Endocarditis
21%
Transplant Recipients
21%
Sepsis
21%
Anti-tumor Necrosis Factor Therapy
19%
Cryptococcosis
18%
Autoimmune Disease
17%
Herpes Zoster
17%
AIDS/HIV
16%
Candidemia
16%
Invasive Fungal Disease
16%
United States
15%
Cryptococcal Meningitis
15%
Amphotericin B
14%
Clinical Outcomes
14%
Immunocompromised Patients
13%
Risk Factors
13%
Racial Differences
13%
Geographical Differences
13%
Infectious Diseases
12%
Invasive Aspergillosis
12%
Incidence Rate
12%
Biologic Therapy
12%
Solid Organ Transplant
12%
Clinical Features
12%
Antifungal Therapy
12%
Non-biologic
12%
Invasive Candidiasis
12%
Cryptococcus Neoformans
12%
Opportunistic Infections
11%
Systemic Juvenile Idiopathic Arthritis (sJIA)
11%
Solid Organ Transplantation
11%
Inflammatory Diseases
11%
Transplantation
11%
Infection Rate
10%
Rheumatoid Arthritis Patients
10%
Itraconazole
10%
Hospital-acquired Infection
10%
Clinical Presentation
10%
Disease-modifying Antirheumatic Drugs (DMARDs)
10%
Posttransplant Infection
10%
Antifungal Susceptibility
10%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Disease
40%
Rheumatoid Arthritis
36%
Histoplasmosis
27%
Biological Product
26%
HIV
24%
Systemic Mycosis
23%
Herpes Zoster
21%
Antifungal Agent
20%
Bacterial Endocarditis
20%
Tumor Necrosis Factor
19%
Mycosis
17%
Antifungal Therapy
17%
Tumor Necrosis Factor Inhibitor
16%
Autoimmune Disease
16%
Sepsis
14%
Candida
14%
Vaccination Policy
14%
Fluconazole
13%
Invasive Candidiasis
12%
Immunocompromised Patient
12%
Amphotericin B
11%
Endocarditis
11%
Opportunistic Infection
11%
Prospective Cohort Study
10%
Candidemia
10%
Inflammatory Disease
10%
Invasive Aspergillosis
10%
Disease Modifying Antirheumatic Drug
10%
Cohort Study
10%
Mould
10%
Itraconazole
9%
Infectious Agent
9%
Juvenile Rheumatoid Arthritis
8%
Candidiasis
8%
Bacteremia
8%
Aspergillus
8%
Bloodstream Infection
8%
SARS Coronavirus
8%
Cryptococcal Meningitis
7%
Etanercept
7%
Pharmacotherapy
7%
Histoplasma
6%
Observational Study
6%
Aspergillosis
6%
Varicella Zoster Vaccine
6%
Adverse Event
6%
Psoriasis
6%
Malignant Neoplasm
6%
Voriconazole
6%
